Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity

Vaccine

Volumn 30, Issue 11, 2012, Pages 1986-1992

  Fraile, Lorenzo ^a,b   Grau Roma, Llorenç ^a,c   Sarasola, Patxi ^d   Sinovas, Nuria ^d   Nofrarías, Miquel ^a   López Jimenez, Rosa ^a   López Soria, Sergio ^a   Sibila, Marina ^a   Segalés, Joaquim ^a,c  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Ondax Scientific ^*  (Spain)

Author keywords

Inactivated vaccine; Maternal immunity interference; Porcine circovirus type 2 (PCV2); Postweaning multisystemic wasting syndrome (PMWS)

Indexed keywords

CIRCOVAC; MATERNAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CIRCOVIRUS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FECES; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MORTALITY; NEWBORN; NONHUMAN; POSTWEANING MULTISYSTEMIC WASTING SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SLAUGHTERHOUSE; VACCINATION; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; DOUBLE-BLIND METHOD; FEMALE; IMMUNITY, HUMORAL; IMMUNITY, MATERNALLY-ACQUIRED; MALE; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SWINE; VACCINATION; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES;

EID: 84857147035     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.008     Document Type: Article

References (34)

1. Grau-Roma L., Fraile L., Segalés J. Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2. Vet J 2011, 187(1):23-32.
2. Segalés J., Allan G.M., Domingo M. Porcine circovirus diseases. Anim Health Res Rev 2005, 6(2):119-142.
3. Madec F., Eveno E., Morvan P., Hamon L., Blanchard P., Cariolet R., et al. Post-weaning multisystemic wasting syndrome (PMWS) in pigs in France: clinical observations from follow-up studies on affected farms. Livest Prod Sci 2000, 63:223-233.
4. López-Soria S., Nofrarías M., Calsamiglia M., Espinal A., Valero O., Ramirez-Mendoza, et al. Post-weaning multisystemic wasting syndrome (PMWS) clinical expression under field conditions is modulated by the pig genetic background. Vet Microbiol 2011, 149(3-4):352-357.
5. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 2007, 19(6):591-615.
6. Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26(11):1488-1499.
7. Cline G., Wilt V., Diaz E., Edler R. Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet Rec 2008, 163(25):737-740.
8. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc 2008, 232(6):906-912.
9. Kixmöller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26(27-28):3443-3451.
10. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26(8):1063-1071.
11. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarías M., et al. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27(52):7313-7321.
12. Desrosiers R., Clark E., Tremblay D., Tremblay R., Polson D. Use of a one-dose subunit vaccine to prevent losses associated with porcine circovirus type 2. J Swine Health Prod 2009, 17:148-154.
13. Reynaud G., Brun A., Charreyre C., Desgouilles S., Jeannin P. Safety of a repeated overdose of an inactivated adjuvanted PCV2 vaccine in conventional pregnant filts and sows. Proc 18th Congress Int Pig Vet Soc 2004.
14. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Ramamoorthy S., Meng X.J., et al. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination. Vet Microbiol 2010, 142(3-4):177-183.
15. Pejsak Z., Podgorska K., Truszczynski M., Karbowiak P., Stadejek T. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS). Comp Immunol Microbiol Infect Dis 2010, 33(6):e1-e5.
16. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 2004, 78(12):6297-6303.
17. Fort M., Sibila M., Pérez-Martin E., Nofrarías M., Mateu E., Segalés J. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009, 27(30):4031-4037.
18. Kekarainen T., McCullough K., Fort M., Fossum C., Segalés J., Allan G.M. Immune responses and vaccine-induced immunity against Porcine circovirus type 2. Vet Immunol Immunopathol 2010, 136(3-4):185-193.
19. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(24):3406-3412.
20. Nguyen T.V., Yuan L., Azevedo M.S., Jeong K.I., Gonzalez A.M., Iosef C., et al. High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen. Clin Vaccine Immunol 2006, 13(4):475-485.
21. Fort M., Fernandes L.T., Nofrarías M., Diaz I., Sibila M., Pujols J., et al. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet Immunol Immunopathol 2009, 129(1-2):101-107.
22. Rosell C., Segalés J., Plana-Duran J., Balasch M., Rodriguez-Arrioja G.M., Kennedy S., et al. Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol 1999, 120(1):59-78.
23. Kennedy S., Segalés J., Rovira A., Scholes S., Domingo M., Moffett D., et al. Absence of evidence of porcine circovirus infection in piglets with congenital tremors. J Vet Diagn Invest 2003, 15(2):151-156.
24. Grau-Roma L., Hjulsager C.K., Sibila M., Kristensen C.S., López-Soria S., Enoe C., et al. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet Microbiol 2009, 135(3-4):272-282.
25. Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. J Virol Methods 2004, 117(1):75-80.
26. Hjulsager C.K., Grau-Roma L., Sibila M., Enoe C., Larsen L., Segalés J. Inter-laboratory and inter-assay comparison on two real-time PCR techniques for quantification of PCV2 nucleic acid extracted from field samples. Vet Microbiol 2009, 133(1-2):172-178.
27. Rodriguez-Arrioja G.M., Segalés J., Balasch M., Rosell C., Quintana J., Folch J.M., et al. Serum antibodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS. Vet Rec 2000, 146(26):762-764.
28. ® in the farm with severe porcine circovirus type 2 disease (PCVD) in post-weaning. Proceedings of the 21st IPVS congress 2010.
29. ® vaccination at 0.5mL in piglets on weight and mortality parameters. Proceedings of the 21st IPVS congress 2010.
30. Opriessnig T., Madson D.M., Prickett J.R., Kuhar D., Lunney J.K., Elsener J., et al. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. Vet Microbiol 2008, 131(1-2):103-114.
31. Morein B., Abusugra I., Blomqvist G. Immunity in neonates. Vet Immunol Immunopathol 2002, 87(3-4):207-213.
32. Elazab M.F., Fukushima Y., Fujita Y., Horiuchi H., Matsuda H., Furusawa S. Induction of immune suppression in the chick by an optimal dose of an immunizing antigen in the presence of its specific maternal antibody. J Vet Med Sci 2010, 72(3):257-262.
33. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clin Vaccine Immunol 2008, 15(3):397-401.
34. Pérez-Martin E., Gomez-Sebastian S., Argilaguet J.M., Sibila M., Fort M., Nofrarías M., et al. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae. Vaccine 2010, 28(11):2340-2349.